The study design and initial 30-day safety data of the BEAT Obesity (Bariatric embolization of arteries for the treatment of obesity) study were presented at the SIR annual scientific meeting in Atlanta.
Premedication with an oral antioxidant cocktail before medical imaging exams could significantly reduce deoxyribonucleic acid (DNA) injury from the ionising radiation dose, finds new research presented at the Society of Interventional Radiology’s annual scientific meeting in Atlanta, USA.
Interventional News has learnt that interventional radiologists and urologists in France are teaming up to set up a multidisciplinary registry to collect data on prostatic artery embolization for the treatment of benign prostatic hyperplasia.
Endovascular treatment of intracranial aneurysm is effective in preventing long-term bleeding, but may be followed by aneurysm recurrences in a significant proportion of cases, according to a new magnetic resonance angiography (MRA) study published online in the journal Radiology.
Allium Medical has announced that it has received FDA clearance to market Gardia’s Wirion system in the United States for the carotid indication.
Following the results of SYMPLICITY HTN-3, which failed to show benefit of renal denervation in resistant hypertension patients, Medtronic announced in April the initiation of the SPYRAL HTN clinical trial programme, studying renal denervation in uncontrolled hypertension. Also in April, Boston Scientific announced the initiation of the REDUCE-HTN: REINFORCE, a randomised, sham-controlled study designed to demonstrate the effects of the Vessix renal denervation system by minimising variability and factors that may have affected results in SYMPLICITY HTN-3.
A combination of imaging systems from Siemens Healthcare is helping Southmead Hospital, Bristol, UK, to achieve its aim of becoming a leading provider of health services in Europe. With the hospital’s new £430m Brunel building offering pioneering treatment within state-of-the-art facilities, Siemens technology is increasing the speed of patient assessment and enabling elevated levels of patient throughput.
The Canadian Society for Vascular Surgery (CSVS) has released a list of specific tests, treatments or procedures that are commonly ordered but not always necessary in vascular surgery as part of the Choosing Wisely Canada campaign. The list identifies five targeted, evidence-based recommendations that can support conversations between patients and physicians about what care is really necessary.
For years, the radiology industry has focused on reducing, or eliminating patient exposure to radiation. Recently, the industry has shifted attention to the cumulative effect radiation exposure has over the course of a physician’s career.
CO2 angiography can decrease both morbidity and mortality for patients, in certain clinical scenarios. For those driven by economics, the cost of 100cc of CO2 is approximately three cents. Its use is limited only by one’s imagination. So why is it not more widely used?
Stentoplasty, or vertebral body stenting, represents the next step in the evolution of cement spinal augmentation where a stent is placed within the vertebral body followed by infusion of cement. Current available systems include the Osseofix system (Alphatec Spine) and the VBS system (Synthes). Uei Pua writes about the future directions of the procedure.
Covidien has announced the six-month results of the VeClose pivotal study, which demonstrated the safety and effectiveness of the VenaSeal closure system in patients with chronic venous insufficiency (CVI) having symptomatic reflux in the great saphenous vein. The results were presented at American College of Phlebology Annual Congress (ACP 2014; Phoenix, USA).
The Gore Viabahn Endoprosthesis has received CE mark approval to improve blood flow in symptomatic obstruction of peripheral veins, excluding the venae cavae and pulmonary veins.
The results of a new study presented at the annual meeting of the Radiological Society of North America (30 November–5 December, Chicago, USA) show that placement of internal iliac balloons is technically feasible, well-tolerated and leads to satisfactory maternal and foetal outcomes with minimal complications.
Medtronic has announced the latest results from two clinical studies analysing the performance of the Endurant AAA stent graft system. The Endurant system has been used to treat more than 165,000 patients worldwide since it was initially introduced in Europe in 2008, which according to a company press release, is more than any other device of its kind, being selected for nearly one of every two endovascular procedures to repair abdominal aortic aneurysms around the world.
Cookies Sociales
Son esos botones que permiten compartir el contenido del sitio web en sus redes sociales (Facebook, Twitter y Linkedin, previo tu consentimiento y login) a través de sistemas totalmente gestionados por dichas redes sociales, así como los recursos (pej. videos) y material que se encuentra en nuestra web, y que de igual manera se presta y gestiona completamente por un tercero.
Si no acepta estas cookies, no podrá compartir nuestro contenido a través de los botones, y en su caso, no podrás visualizar el contenido de terceros que hayamos incrustado en el sitio.
No las utilizamos